Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Field testing of a household-scale onsite blackwater treatment system in Coimbatore, India.

Welling CM, Sasidaran S, Kachoria P, Hennessy S, Lynch BJ, Teleski S, Chaudhari H, Sellgren KL, Stoner BR, Grego S, Hawkins BT.

Sci Total Environ. 2020 Apr 15;713:136706. doi: 10.1016/j.scitotenv.2020.136706. Epub 2020 Jan 15.

2.

Field testing of a household-scale onsite blackwater treatment system in South Africa.

Sahondo T, Hennessy S, Sindall RC, Chaudhari H, Teleski S, Lynch BJ, Sellgren KL, Stoner BR, Grego S, Hawkins BT.

Sci Total Environ. 2020 Feb 10;703:135469. doi: 10.1016/j.scitotenv.2019.135469. Epub 2019 Nov 11.

3.

Improving energy efficiency of electrochemical blackwater disinfection through sequential reduction of suspended solids and chemical oxygen demand.

Hawkins BT, Rogers TW, Davey CJ, Stoner MH, McAdam EJ, Stoner BR.

Version 2. Gates Open Res. 2019 Jan 23 [revised 2019 Jan 1];2:50. doi: 10.12688/gatesopenres.12873.2. eCollection 2018.

4.

Remediation of suspended solids and turbidity by improved settling tank design in a small-scale, free-standing toilet system using recycled blackwater.

Hawkins BT, Sellgren KL, Cellini E, J D Klem E, Rogers T, Lynch BJ, Piascik JR, Stoner BR.

Water Environ J. 2019 Feb;33(1):61-66. doi: 10.1111/wej.12369. Epub 2018 Sep 17.

5.

A granular activated carbon/electrochemical hybrid system for onsite treatment and reuse of blackwater.

Rogers TW, Rogers TS, Stoner MH, Sellgren KL, Lynch BJ, Forbis-Stokes AA, Stoner BR, Hawkins BT.

Water Res. 2018 Nov 1;144:553-560. doi: 10.1016/j.watres.2018.07.070. Epub 2018 Jul 30.

6.

Improved blackwater disinfection using potentiodynamic methods with oxidized boron-doped diamond electrodes.

Thostenson JO, Mourouvin R, Hawkins BT, Ngaboyamahina E, Sellgren KL, Parker CB, Deshusses MA, Stoner BR, Glass JT.

Water Res. 2018 Sep 1;140:191-199. doi: 10.1016/j.watres.2018.04.022. Epub 2018 Apr 18.

7.

Three-dimensional (3D) tetra-culture brain on chip platform for organophosphate toxicity screening.

Koo Y, Hawkins BT, Yun Y.

Sci Rep. 2018 Feb 12;8(1):2841. doi: 10.1038/s41598-018-20876-2.

8.

Electrochemical disinfection of repeatedly recycled blackwater in a free-standing, additive-free toilet.

Hawkins BT, Sellgren KL, Klem EJD, Piascik JR, Stoner BR.

Water Environ J. 2017 Nov;31(4):545-551. doi: 10.1111/wej.12277. Epub 2017 Jul 23.

9.

β1-integrin-matrix interactions modulate cerebral microvessel endothelial cell tight junction expression and permeability.

Izawa Y, Gu YH, Osada T, Kanazawa M, Hawkins BT, Koziol JA, Papayannopoulou T, Spatz M, Del Zoppo GJ.

J Cereb Blood Flow Metab. 2018 Apr;38(4):641-658. doi: 10.1177/0271678X17722108. Epub 2017 Aug 8.

10.

Enhanced H2O2 Production at Reductive Potentials from Oxidized Boron-Doped Ultrananocrystalline Diamond Electrodes.

Thostenson JO, Ngaboyamahina E, Sellgren KL, Hawkins BT, Piascik JR, Klem EJD, Parker CB, Deshusses MA, Stoner BR, Glass JT.

ACS Appl Mater Interfaces. 2017 May 17;9(19):16610-16619. doi: 10.1021/acsami.7b01614. Epub 2017 May 4.

11.

Systems biology for organotypic cell cultures.

Grego S, Dougherty ER, Alexander FJ, Auerbach SS, Berridge BR, Bittner ML, Casey W, Cooley PC, Dash A, Ferguson SS, Fennell TR, Hawkins BT, Hickey AJ, Kleensang A, Liebman MNJ, Martin F, Maull EA, Paragas J, Qiao GG, Ramaiahgari S, Sumner SJ, Yoon M.

ALTEX. 2017;34(2):301-310. doi: 10.14573/altex.1608221. Epub 2016 Nov 14.

12.

An optically transparent membrane supports shear stress studies in a three-dimensional microfluidic neurovascular unit model.

Sellgren KL, Hawkins BT, Grego S.

Biomicrofluidics. 2015 Nov 12;9(6):061102. doi: 10.1063/1.4935594. eCollection 2015 Nov.

13.

Three-dimensional culture conditions differentially affect astrocyte modulation of brain endothelial barrier function in response to transforming growth factor β1.

Hawkins BT, Grego S, Sellgren KL.

Brain Res. 2015 May 22;1608:167-76. doi: 10.1016/j.brainres.2015.02.025. Epub 2015 Feb 23.

PMID:
25721792
14.

Dabigatran abrogates brain endothelial cell permeability in response to thrombin.

Hawkins BT, Gu YH, Izawa Y, del Zoppo GJ.

J Cereb Blood Flow Metab. 2015 Jun;35(6):985-92. doi: 10.1038/jcbfm.2015.9. Epub 2015 Feb 11.

15.

Hemostasis and alterations of the central nervous system.

del Zoppo GJ, Izawa Y, Hawkins BT.

Semin Thromb Hemost. 2013 Nov;39(8):856-75. doi: 10.1055/s-0033-1357490. Epub 2013 Oct 28. Review.

16.

Disruption of dystroglycan-laminin interactions modulates water uptake by astrocytes.

Hawkins BT, Gu YH, Izawa Y, Del Zoppo GJ.

Brain Res. 2013 Mar 29;1503:89-96. doi: 10.1016/j.brainres.2013.01.049. Epub 2013 Feb 5.

17.

Targeting blood-brain barrier sphingolipid signaling reduces basal P-glycoprotein activity and improves drug delivery to the brain.

Cannon RE, Peart JC, Hawkins BT, Campos CR, Miller DS.

Proc Natl Acad Sci U S A. 2012 Sep 25;109(39):15930-5. Epub 2012 Sep 4.

18.

Interendothelial claudin-5 expression depends on cerebral endothelial cell-matrix adhesion by β(1)-integrins.

Osada T, Gu YH, Kanazawa M, Tsubota Y, Hawkins BT, Spatz M, Milner R, del Zoppo GJ.

J Cereb Blood Flow Metab. 2011 Oct;31(10):1972-85. doi: 10.1038/jcbfm.2011.99. Epub 2011 Jul 20.

19.

Activating PKC-β1 at the blood-brain barrier reverses induction of P-glycoprotein activity by dioxin and restores drug delivery to the CNS.

Wang X, Hawkins BT, Miller DS.

J Cereb Blood Flow Metab. 2011 Jun;31(6):1371-5. doi: 10.1038/jcbfm.2011.44. Epub 2011 Apr 13.

20.

Aryl hydrocarbon receptor-mediated up-regulation of ATP-driven xenobiotic efflux transporters at the blood-brain barrier.

Wang X, Hawkins BT, Miller DS.

FASEB J. 2011 Feb;25(2):644-52. doi: 10.1096/fj.10-169227. Epub 2010 Nov 3.

21.

Throwing out the thromboemboli.

del Zoppo GJ, Hawkins BT.

N Engl J Med. 2010 Sep 23;363(13):1282-4. doi: 10.1056/NEJMcibr1006572. No abstract available.

PMID:
20860513
22.

Rapid loss of blood-brain barrier P-glycoprotein activity through transporter internalization demonstrated using a novel in situ proteolysis protection assay.

Hawkins BT, Rigor RR, Miller DS.

J Cereb Blood Flow Metab. 2010 Sep;30(9):1593-7. doi: 10.1038/jcbfm.2010.117. Epub 2010 Jul 14.

23.

Activation of PKC isoform beta(I) at the blood-brain barrier rapidly decreases P-glycoprotein activity and enhances drug delivery to the brain.

Rigor RR, Hawkins BT, Miller DS.

J Cereb Blood Flow Metab. 2010 Jul;30(7):1373-83. doi: 10.1038/jcbfm.2010.21. Epub 2010 Mar 3.

24.

Rapid, reversible modulation of blood-brain barrier P-glycoprotein transport activity by vascular endothelial growth factor.

Hawkins BT, Sykes DB, Miller DS.

J Neurosci. 2010 Jan 27;30(4):1417-25. doi: 10.1523/JNEUROSCI.5103-09.2010.

25.

Pathophysiology of the blood-brain barrier: animal models and methods.

Hawkins BT, Egleton RD.

Curr Top Dev Biol. 2008;80:277-309. Review.

PMID:
17950377
26.

Comparative changes in the blood-brain barrier and cerebral infarction of SHR and WKY rats.

Hom S, Fleegal MA, Egleton RD, Campos CR, Hawkins BT, Davis TP.

Am J Physiol Regul Integr Comp Physiol. 2007 May;292(5):R1881-92. Epub 2007 Jan 18.

27.

Increased blood-brain barrier permeability and altered tight junctions in experimental diabetes in the rat: contribution of hyperglycaemia and matrix metalloproteinases.

Hawkins BT, Lundeen TF, Norwood KM, Brooks HL, Egleton RD.

Diabetologia. 2007 Jan;50(1):202-11. Epub 2006 Dec 2.

PMID:
17143608
28.

Decreased blood-brain barrier permeability to fluorescein in streptozotocin-treated rats.

Hawkins BT, Ocheltree SM, Norwood KM, Egleton RD.

Neurosci Lett. 2007 Jan 3;411(1):1-5. Epub 2006 Nov 15.

29.

Fluorescence imaging of blood-brain barrier disruption.

Hawkins BT, Egleton RD.

J Neurosci Methods. 2006 Mar 15;151(2):262-7. Epub 2005 Sep 21.

PMID:
16181683
30.

The blood-brain barrier/neurovascular unit in health and disease.

Hawkins BT, Davis TP.

Pharmacol Rev. 2005 Jun;57(2):173-85. Review.

PMID:
15914466
31.

Chronic inflammatory pain leads to increased blood-brain barrier permeability and tight junction protein alterations.

Brooks TA, Hawkins BT, Huber JD, Egleton RD, Davis TP.

Am J Physiol Heart Circ Physiol. 2005 Aug;289(2):H738-43. Epub 2005 Mar 25.

32.

Modulation of cerebral microvascular permeability by endothelial nicotinic acetylcholine receptors.

Hawkins BT, Egleton RD, Davis TP.

Am J Physiol Heart Circ Physiol. 2005 Jul;289(1):H212-9. Epub 2005 Feb 11.

33.

Nicotine increases in vivo blood-brain barrier permeability and alters cerebral microvascular tight junction protein distribution.

Hawkins BT, Abbruscato TJ, Egleton RD, Brown RC, Huber JD, Campos CR, Davis TP.

Brain Res. 2004 Nov 19;1027(1-2):48-58.

PMID:
15494156
34.
35.

Smoking and ischemic stroke: a role for nicotine?

Hawkins BT, Brown RC, Davis TP.

Trends Pharmacol Sci. 2002 Feb;23(2):78-82. Review.

PMID:
11830264

Supplemental Content

Loading ...
Support Center